During the past decade, Tor Vergata Univerisity Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tor Vergata Univerisity Hospital" are "Cicatrix" (1 trials), "Hypertrophic Scar" (1 trials), "Keloid" (1 trials), "Nail Diseases" (1 trials) and "Onychomycosis" (1 trials). Many other conditions were trialed in "Tor Vergata Univerisity Hospital" in a lesser frequency.

Most popular intervention types in "Tor Vergata Univerisity Hospital" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amorolfine 50 MG/ML" (1 trials), "Ciclopirox Topical Gel" (1 trials), "Itraconazole 200 mg" (1 trials), "Kaloidon Plus" (1 trials) and "Terbinafine 250 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tor Vergata Univerisity Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tor Vergata Univerisity Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tor Vergata Univerisity Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tor Vergata Univerisity Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".